Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 19Rectal Neoplasms 11Colorectal Neoplasms 11Colonic Neoplasms 11Central Nervous System Neoplasms 8Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 4Liver Neoplasms 4Kidney Neoplasms 4Carcinoma, Hepatocellular 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Lymphatic Metastasis 2Glioblastoma 2Breast Neoplasms, Male 2Astrocytoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1

Interventions

Gefitinib 3Neoadjuvant Therapy 2Gemcitabine 2Erlotinib Hydrochloride 2motesanib diphosphate 1Paclitaxel 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma, Bronchiolo-Alveolar × Chemotherapy, Adjuvant × Clear all
NCT00398385 2013-08-12

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
170 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡